Efficacy and Safety of Milrinone in Preventing Low Cardiac Output Syndrome in Infants and Children After Corrective Surgery for Congenital Heart Disease

By T. M. Hoffman, G. Wernovsky, A. Atz, T. Kulik, D. Nelson, A. Chang, J. Bailey, A. Akbary, J. F. Kocsis, R. Kaczmarek and 2 more. Circulation, 2003

737 citations recorded by the source corpus.

Subfields: Biomedical Engineering, Cardiology and Cardiovascular Medicine, Epidemiology

View Paper: https://www.semanticscholar.org/paper/c44f2fc1e25a4aad3c3c2da3b0a2a943945a4207

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. M. Napoli
2. A. Yen
3. J. Gurney
4. J. Hirsch
5. R. Ohye
6. M. Gaies
7. R. Gajarski
8. J. Charpie

Citations in the corpus

• Vasoactive–inotropic score as a predictor of morbidity and mortality in infants after cardiopulmonary bypass* (2010, background): “Hoffman and colleagues demonstrated in a randomized, placebo-controlled trial that prophylactic administration of milrinone may prevent the onset of low cardiac output syndrome in patients undergoing repair or palliation of biventricular congenital heart disease (16).”